295 related articles for article (PubMed ID: 25762828)
1. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
3. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Grasso M; Remacle M; Bachy V; Van Der Vorst S; Lawson G
Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2983-90. PubMed ID: 24756616
[TBL] [Abstract][Full Text] [Related]
4. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
5. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
6. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
7. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
[TBL] [Abstract][Full Text] [Related]
9. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
10. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
[TBL] [Abstract][Full Text] [Related]
12. Use of cidofovir for treatment of recurrent respiratory papillomatosis.
Derkay C
Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):198-201. PubMed ID: 19221249
[No Abstract] [Full Text] [Related]
13. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
14. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
15. Use of cidofovir in recurrent respiratory papillomatosis.
Carifi M
Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2165-6. PubMed ID: 23545883
[No Abstract] [Full Text] [Related]
16. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
[TBL] [Abstract][Full Text] [Related]
17. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
19. Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study.
Solarz P; Bodnar M; Czech J; Mackiewicz-Nartowicz H; Sinkiewicz A; Szylberg Ł; Borowczak J; Rutkiewicz P; Zwierz A; Burduk P
J Med Virol; 2023 Jan; 95(1):e28303. PubMed ID: 36369954
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
